| Mean Age Years (±SD) | 1600 | 56.6 (±12.6) |
| Mean Duration of DM Treatment Years (±SD) | 1600 | 7.2 ± 4.9 |
| Gender |
| |
| Female | 1020 | 63.8% |
| Male | 580 | 36.2% |
| Type of DM |
| |
| Type 1 | 68 | 4.3% |
| Type 2 | 1532 | 95.7% |
| BMI | ||
| Underweight (<18.5) | 18 | 1.1% |
| Normal weight (18.5 - 24.9) | 137 | 8.6% |
| Overweight (25 - 29.9) | 421 | 26.3% |
| Obese (≥30) | 1024 | 64.0% |
| Comorbid hypertension | 1102 | 68.9% |
| BP > 140/90 mmHg | 490 | 44.5% |
| BP > 130/80 mmHg | 792 | 71.8% |
| 2 hr PPG result available | 1515 | 94.7% |
| 2 h PPG ≥ 180 mg% | 799 | 52.7% |
| HbA1c tested during study | 1600 | 100% |
| HbA1c ≥ 7.0% | 1148 | 71.8% |
| S Cholesterol results available | 1543 | 96.4% |
| S Cholesterol ≥ 200 mg% | 614 | 39.8% |
| S Creatinine results available | 1534 | 91.4% |
| S Creatinine > 1.2 mg% | 98 | 6.4% |
| Proteinuria results available | 1400 | 87.5% |
| Macro albuminuria + ve | 144 | 10.3% |
| Fundoscopy results available | 757 | 47.3% |
| Retinopathy + ve | 83 | 11.0% |